Overexpression of COL1A1 and COL1A2 has been confirmed in GC (Li et al., 2016; Sun, 2016; Zhuo et al., 2016; Wang and Yu, 2018) and may predict an adverse prognosis in GC patients (Li et al., 2016). The gene discussed is COL1A1; the disease is gastric cancer.